250 related articles for article (PubMed ID: 25880213)
1. A mutation screening of oncogenes, tumor suppressor gene TP53 and nuclear encoded mitochondrial complex I genes in oncocytic thyroid tumors.
Evangelisti C; de Biase D; Kurelac I; Ceccarelli C; Prokisch H; Meitinger T; Caria P; Vanni R; Romeo G; Tallini G; Gasparre G; Bonora E
BMC Cancer; 2015 Mar; 15():157. PubMed ID: 25880213
[TBL] [Abstract][Full Text] [Related]
2. Disruptive mitochondrial DNA mutations in complex I subunits are markers of oncocytic phenotype in thyroid tumors.
Gasparre G; Porcelli AM; Bonora E; Pennisi LF; Toller M; Iommarini L; Ghelli A; Moretti M; Betts CM; Martinelli GN; Ceroni AR; Curcio F; Carelli V; Rugolo M; Tallini G; Romeo G
Proc Natl Acad Sci U S A; 2007 May; 104(21):9001-6. PubMed ID: 17517629
[TBL] [Abstract][Full Text] [Related]
3. Papillary thyroid carcinoma tall cell variant shares accumulation of mitochondria, mitochondrial DNA mutations, and loss of oxidative phosphorylation complex I integrity with oncocytic tumors.
Tsybrovskyy O; De Luise M; de Biase D; Caporali L; Fiorini C; Gasparre G; Carelli V; Hackl D; Imamovic L; Haim S; Sobrinho-Simões M; Tallini G
J Pathol Clin Res; 2022 Mar; 8(2):155-168. PubMed ID: 34792302
[TBL] [Abstract][Full Text] [Related]
4. Defective oxidative phosphorylation in thyroid oncocytic carcinoma is associated with pathogenic mitochondrial DNA mutations affecting complexes I and III.
Bonora E; Porcelli AM; Gasparre G; Biondi A; Ghelli A; Carelli V; Baracca A; Tallini G; Martinuzzi A; Lenaz G; Rugolo M; Romeo G
Cancer Res; 2006 Jun; 66(12):6087-96. PubMed ID: 16778181
[TBL] [Abstract][Full Text] [Related]
5. Near-haploidization significantly associates with oncocytic adrenocortical, thyroid, and parathyroid tumors but not with mitochondrial DNA mutations.
Corver WE; van Wezel T; Molenaar K; Schrumpf M; van den Akker B; van Eijk R; Ruano Neto D; Oosting J; Morreau H
Genes Chromosomes Cancer; 2014 Oct; 53(10):833-44. PubMed ID: 24909752
[TBL] [Abstract][Full Text] [Related]
6. Oncocytic tumors are marked by enhanced mitochondrial content and mtDNA mutations of complex I in Chinese patients.
Lyu L; Wang Q; Song S; Li L; Zhou H; Li M; Jiang Z; Zhou C; Chen G; Lyu J; Bai Y
Mitochondrion; 2019 Mar; 45():1-6. PubMed ID: 29386142
[TBL] [Abstract][Full Text] [Related]
7. PTEN and TP53 Mutations in Oncocytic Follicular Carcinoma.
Wei S; LiVolsi VA; Montone KT; Morrissette JJ; Baloch ZW
Endocr Pathol; 2015 Dec; 26(4):365-9. PubMed ID: 26530486
[TBL] [Abstract][Full Text] [Related]
8. Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations.
Quiros RM; Ding HG; Gattuso P; Prinz RA; Xu X
Cancer; 2005 Jun; 103(11):2261-8. PubMed ID: 15880523
[TBL] [Abstract][Full Text] [Related]
9. High frequency of somatic mitochondrial DNA mutations in human thyroid carcinomas and complex I respiratory defect in thyroid cancer cell lines.
Abu-Amero KK; Alzahrani AS; Zou M; Shi Y
Oncogene; 2005 Feb; 24(8):1455-60. PubMed ID: 15608681
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial DNA somatic mutations (point mutations and large deletions) and mitochondrial DNA variants in human thyroid pathology: a study with emphasis on Hürthle cell tumors.
Máximo V; Soares P; Lima J; Cameselle-Teijeiro J; Sobrinho-Simões M
Am J Pathol; 2002 May; 160(5):1857-65. PubMed ID: 12000737
[TBL] [Abstract][Full Text] [Related]
11. RET/papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: follicular cells of Hashimoto's thyroiditis share low-level recombination events with a subset of papillary carcinoma.
Rhoden KJ; Unger K; Salvatore G; Yilmaz Y; Vovk V; Chiappetta G; Qumsiyeh MB; Rothstein JL; Fusco A; Santoro M; Zitzelsberger H; Tallini G
J Clin Endocrinol Metab; 2006 Jun; 91(6):2414-23. PubMed ID: 16595592
[TBL] [Abstract][Full Text] [Related]
12. Encapsulated papillary oncocytic neoplasms of the thyroid: morphologic, immunohistochemical, and molecular analysis of 18 cases.
Woodford RL; Nikiforov YE; Hunt JL; Bellizzi AM; Zhang X; Mills SE; Stelow EB
Am J Surg Pathol; 2010 Nov; 34(11):1582-90. PubMed ID: 20924280
[TBL] [Abstract][Full Text] [Related]
13. Aneuploidy in oncocytic lesions of the thyroid gland: diffuse accumulation of mitochondria within the cell is associated with trisomy 7 and progressive numerical chromosomal alterations.
Dettori T; Frau DV; Lai ML; Mariotti S; Uccheddu A; Daniele GM; Tallini G; Faa G; Vanni R
Genes Chromosomes Cancer; 2003 Sep; 38(1):22-31. PubMed ID: 12874783
[TBL] [Abstract][Full Text] [Related]
14. MEN1 mutations in Hürthle cell (oncocytic) thyroid carcinoma.
Kasaian K; Chindris AM; Wiseman SM; Mungall KL; Zeng T; Tse K; Schein JE; Rivera M; Necela BM; Kachergus JM; Casler JD; Mungall AJ; Moore RA; Marra MA; Copland JA; Thompson EA; Smallridge RC; Jones SJ
J Clin Endocrinol Metab; 2015 Apr; 100(4):E611-5. PubMed ID: 25625803
[TBL] [Abstract][Full Text] [Related]
15. Analysis of nuclear and mitochondrial DNA alterations in thyroid and renal oncocytic tumors.
Tallini G; Ladanyi M; Rosai J; Jhanwar SC
Cytogenet Cell Genet; 1994; 66(4):253-9. PubMed ID: 7909283
[TBL] [Abstract][Full Text] [Related]
16. Cardiolipins Are Biomarkers of Mitochondria-Rich Thyroid Oncocytic Tumors.
Zhang J; Yu W; Ryu SW; Lin J; Buentello G; Tibshirani R; Suliburk J; Eberlin LS
Cancer Res; 2016 Nov; 76(22):6588-6597. PubMed ID: 27659048
[TBL] [Abstract][Full Text] [Related]
17. Methylation profile of TP53 regulatory pathway and mtDNA alterations in breast cancer patients lacking TP53 mutations.
Barekati Z; Radpour R; Kohler C; Zhang B; Toniolo P; Lenner P; Lv Q; Zheng H; Zhong XY
Hum Mol Genet; 2010 Aug; 19(15):2936-46. PubMed ID: 20466735
[TBL] [Abstract][Full Text] [Related]
18. Centralized molecular testing for oncogenic gene mutations complements the local cytopathologic diagnosis of thyroid nodules.
Beaudenon-Huibregtse S; Alexander EK; Guttler RB; Hershman JM; Babu V; Blevins TC; Moore P; Andruss B; Labourier E
Thyroid; 2014 Oct; 24(10):1479-87. PubMed ID: 24811481
[TBL] [Abstract][Full Text] [Related]
19. Interphase cytogenetics in oncocytic adenomas and carcinomas of the thyroid gland.
Mazzucchelli L; Burckhardt E; Hirsiger H; Kappeler A; Laissue JA
Hum Pathol; 2000 Jul; 31(7):854-9. PubMed ID: 10923924
[TBL] [Abstract][Full Text] [Related]
20. Respiratory chain complex I is a mitochondrial tumor suppressor of oncocytic tumors.
Zimmermann FA; Mayr JA; Feichtinger R; Neureiter D; Lechner R; Koegler C; Ratschek M; Rusmir H; Sargsyan K; Sperl W; Kofler B
Front Biosci (Elite Ed); 2011 Jan; 3(1):315-25. PubMed ID: 21196312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
